Another new product that will make a splash in the fertility market was just launched by Repromedix Corporation. The product Plan Ahead, is a blood test that provides an evaluation of a woman’s egg supply. The estimated results come from comparing tested egg supply levels to those of healthy and fertile woman of the same age.
This is significant because most of the time, a woman’s egg supply is evaluated through egg retrieval procedures. The ability to extract the same information with a simple blood test will prove useful for woman as they assess when they should try to start their family.
For more information: http:/wwwplanaheadtest.com/us.
Comments
Post new comment